Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.
Carrie C, Muracciole X, Gomez F, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Soum F, Baron MH, Clavere P, Chapet S, Gaci Z, Kolodie H, Maingon P, Vie B, Bernier V, Alapetite C, Hoffstetter S, Grill J, Lafay F; French Society of Pediatric Oncology. Carrie C, et al. Among authors: maingon p. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):711-6. doi: 10.1016/j.ijrobp.2005.03.031. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927408 Clinical Trial.
Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.
Martinet S, Ozsahin M, Belkacémi Y, Landmann C, Poortmans P, Oehlere C, Scandolaro L, Krengli M, Maingon P, Miralbell R, Studer G, Chauvet B, Marnitz S, Zouhair A, Mirimanoff RO. Martinet S, et al. Among authors: maingon p. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):892-8. doi: 10.1016/s0360-3016(02)04159-7. Int J Radiat Oncol Biol Phys. 2003. PMID: 12605966
Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.
Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, Barbet N, Maingon P, Mahe M, Baulieux J, Partensky C, Papillon M, Glehen O, Crozet B, Grandjean JP, Adeleine P. Gerard JP, et al. Among authors: maingon p. J Clin Oncol. 2004 Jun 15;22(12):2404-9. doi: 10.1200/JCO.2004.08.170. J Clin Oncol. 2004. PMID: 15197202 Clinical Trial.
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.
Beckendorf V, Guérif S, Le Prisé E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P. Beckendorf V, et al. Among authors: maingon p. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1056-65. doi: 10.1016/j.ijrobp.2004.05.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519775 Clinical Trial.
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, Maingon P, Giraud P, Bourhis J, Marchesi V, Mège A, Peiffert D. Graff P, et al. Among authors: maingon p. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1309-17. doi: 10.1016/j.ijrobp.2006.11.012. Epub 2007 Feb 7. Int J Radiat Oncol Biol Phys. 2007. PMID: 17289292
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart S. Carrie C, et al. Among authors: maingon p. J Clin Oncol. 2009 Apr 10;27(11):1879-83. doi: 10.1200/JCO.2008.18.6437. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273707
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial.
Bolla M, Hannoun-Levi JM, Ferrero JM, Maingon P, Buffet-Miny J, Bougnoux A, Bauer J, Descotes JL, Fourneret P, Jover F, Colonna M. Bolla M, et al. Among authors: maingon p. Radiother Oncol. 2010 Nov;97(2):312-7. doi: 10.1016/j.radonc.2010.08.012. Epub 2010 Sep 16. Radiother Oncol. 2010. PMID: 20846737 Clinical Trial.
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.
Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, Salem N, Chapet O, Bourdain S, Bachaud JM, Maingon P, Hannoun-Levi JM, Malissard L, Simon JM, Pommier P, Hay M, Dubray B, Lagrange JL, Luporsi E, Bey P. Beckendorf V, et al. Among authors: maingon p. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1056-63. doi: 10.1016/j.ijrobp.2010.03.049. Epub 2010 Dec 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 21147514 Clinical Trial.
301 results